Protagenic Therapeutics, Inc.new (PTIX) Net Short-Term Debt Issued (Repaid) (2016)
Protagenic Therapeutics, Inc.new (PTIX) recorded Net Short-Term Debt Issued (Repaid) of $19,000 in FY2016 (year ended Dec 31, 2016), down 95.1% from $387,630 in FY2015.
Analysis
Protagenic Therapeutics, Inc.new (PTIX) Net Short-Term Debt Issued (Repaid) (2016) Analysis & Trends
- Per Business Quant data, PTIX's Net Short-Term Debt Issued (Repaid) was $387,630 in FY2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net ST Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,305.71 Bn | 1,279.33 Bn | 20.46 Bn | -5.28 Bn |
| 2 | Johnson & Johnson | 694.23 Bn | 614.09 Bn | 17.30 Bn | 2.28 Bn |
| 3 | AbbVie | 528.96 Bn | 496.97 Bn | 13.12 Bn | -499.00 Mn |
| 4 | Merck | 365.92 Bn | 328.86 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 314.95 Bn | 288.19 Bn | - | -682.00 Mn |
| 6 | Astrazeneca | 289.15 Bn | 262.67 Bn | 13.26 Bn | - |
| 7 | Amgen | 254.11 Bn | 205.76 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 211.85 Bn | 186.96 Bn | 6.73 Bn | - |
| 9 | Pfizer | 165.73 Bn | 113.09 Bn | 12.56 Bn | -87.00 Mn |
| 10 | Protagenic Therapeutics, Inc.new | 850,797.76 | -3.51 Mn | - | - |
API Access
Protagenic Therapeutics, Inc.new Net Short-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-debt&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-debt", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-debt&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();